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Abstract
A 24-year-old male thyrotoxic student of a tertiary institution had thyroidectomy in the presence of a persistently elevated 
thyroxine (T4) and tri-iodothyronine (T3) levels. He was initially managed for hypertension at a private hospital before he 
was referred to our hospital for expert management. He had symptoms of thyrotoxicosis three years before presentation 
at our hospital. Physical examination revealed bilateral anterior neck masses and a diagnosis of toxic goitre was made. 
The serum T3 and T4 were elevated. Chest X-Ray, electrocardiogram and echocardiography showed abnormal findings. 
He was commenced on antithyroid drugs. Surgery was postponed several times due to persistently elevated thyroid 
hormones. However, he developed cardiac failure after six months on medical treatment and was treated with digoxin 
and frusemide. He had thyroidectomy under general anesthesia after his cardiovascular status was optimized in order 
to prevent further deterioration of his cardiac function. The anesthetic management is presented and discussed.
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Thyroid diseases and thyrotoxicosis are common in many 
African countries.[1,2] The classical features of thyrotoxicosis 
are hyperactivity, weight loss, and tremor. Of importance 
to the anesthetist are the cardiovascular effects of 
hyperthyroidism including atrial fibrillation, congestive 
cardiac failure, and ischemic heart disease.[3] Treatment of 
thyrotoxicosis include medical therapy, radioactive iodine 
and surgery. 
While subtotal thyroidectomy is now less commonly 
performed for toxic goitres in developed countries,[4] 
it remains the mainstay of management in developing 
countries.[5,6] In an attempt to prevent a thyroid storm, 
patients are usually rendered euthyroid before surgery by 
using anti-thyroid drugs. 
A series of successful thyroidectomies in non-euthyroid 
patients in this environment has been reported.[5] The 
necessity for surgery was attributed to the fact that 
antithyroid drugs were beyond the reach of some of these 
patients because of the cost. Apart from the cost, failure 
of antithyroid therapy in our environment can result from 
non-compliance on medication by patients due to long 
duration of therapy or the drugs could have lost their 
potencies due to logistic reasons. In these circumstances, 
the cardiovascular effects of hyperthyroidism get worse. In 
order to ameliorate these effects, there may be a need to 
operate on a non-euthyroid patient as long as precautionary 
measures are taken to prevent a ‘thyroid crisis’ 
Case Report
A 24-year-old male university student presented with 
a three-year history of excessive sweating, undue heat 
intolerance, weight loss and palpitations, an, a month 
history of easy fatigability. He did not notice that he had 
an associated anterior neck swelling. He was managed for 
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hypertension in a private hospital but was referred because 
of poor response.
Physical examination revealed a young man weighing 
70 kg with mild bilateral proptosis, lid lag, and lid retraction. 
There were fine tremors of the outstretched hands and the 
palms were warm. He had bilateral anterior neck masses, 
multinodular, and non-tender; the right mass measuring 
8 cm×6 cm while the left measured 5 cm×5 cm. The 
trachea was deviated to the right. The pulse rate was 
96 bpm, regular rhythm and the apex beat was displaced 
to the 6th left intercostal space lateral to the mid-clavicular 
line. The heart sounds were normal. A diagnosis of toxic 
multinodular goitre was made.
Investigations revealed a hematocrit of 36%, white cell 
count 4.6×109/l (normal differential count), platelet count 
129×109/l. Serum electrolytes and urea- Na+ 135 mmol/l, 
K+ 3.9 mmol/l, urea 7.7 mmol/l, creatinine 8.3 µmol/l, Ca2+ 
2.30 mmol/l, phosphate 1.3 mmol/l. Urinalysis was normal.
Electrocardiogram showed sinus tachycardia, bilateral 
atrial enlargement, and left ventricular hypertrophy while 
echocardiography showed dilated left atrium and ventricle 
with normal left ventricular systolic and diastolic function. 
There was moderate regurgitation across the mitral and 
tricuspid valves. Chest X-ray showed soft tissue swelling 
in the anterior neck region with tracheal deviation to the 
right. The lung fields were clear. There was cardiomegaly 
with left ventricular preponderance. 
The patient was commenced on anti-thyroid therapy with 
carbimazole 15 mg, 8 hourly, propranolol 40 mg b.d., and 
diazepam 5 mg b.d. on an outpatient basis. Surgery was 
postponed several times because of persistently elevated T3 
and T4 [Table 1]. He developed congestive cardiac failure 
six months after commencing anti-thyroid medication and 
was treated with oral digoxin 0.125 mg daily and frusemide 
40 mg. Antithyroid therapy was later reviewed to include 
Lugol’s iodine 5 drops t.i.d. and oral dexamethasone 4 mg 
t.i.d., while carbimazole was increased to 20 mg t.i.d. In order 
to prevent further deterioration of his cardiac function, he 
had subtotal thyroidectomy under general anesthesia nine 
months after he presented although the serum T3 and T4 
were still elevated [Table 1]. Lugol’s iodine was discontinued 
48 hrs before surgery. The sleeping pulse rate ranged 
between 67-82 bpm three weeks before surgery.
Anesthetic management
The patient was calm during the pre-anesthetic visit. The 
pulse was 80 bpm, while the blood pressure was 130/80 
mmHg. The hematocrit was 42%. He was classified as 
American Society of Anesthesiologists’ (ASA) physical 
status 2 with a Mallampati airway grade 2. Two units 
of whole blood were cross-matched for surgery. He was 
premedicated with 10 mg oral diazepam on the morning of 
surgery while he also had his antithyroid drugs.
In the operating room, a multi-parameter patient monitor, 
“Nellcor-Puritan-Bennette NPB 4000” was used to monitor 
the patient and the baseline parameters were: Blood pressure 
126/78 mmHg, heart rate 84beats/min, arterial oxygen 
saturation (SpO2) 98-100% (room air), temperature 36.8°C. 
The ECG was continuously monitored intraoperatively. 
An intravenous access was secured with an 18 g cannula. 
Intravenous lidocaine, dopamine, and a defibrillator were 
available for emergency use. 
During pre-oxygenation, he had 3 µg/kg of fentanyl followed 
by 1.5 mg/kg of lidocaine iv. Anesthesia was induced with 
6 mg/kg of sodium thiopenthal and tracheal intubation was 
facilitated with 1.5 mg/kg suxamethonium iv. The lungs 
were ventilated with 50% nitrous oxide in oxygen using a 
Bain breathing system with a total fresh gas flow of 6l/min. 
Anesthesia was supplemented with isoflurane 1%.
Neuromuscular paralysis was initially achieved with 
atracurium 0.5 mg/kg followed by supplemental doses of 
0.1 mg/kg increments up to a total dose of 80 mg. Further 
analgesia was continued with fentanyl given in 50 µg 
increments up to a total dose of 375 µg.
At surgery, a highly vascularised and grossly enlarged thyroid 
gland was found. Subtotal thyroidectomy was done. The 
gland weighed 225 g.
Intraoperatively, the monitored parameters were all within 
normal range. Intra-operative blood loss was 550 ml and 
fluid therapy consisted of 2 l of normal saline within 
surgery and anesthesia time of 3 h 10 min and 3 h 35 min, 
respectively. No intraoperative adverse event was recorded.
At the end of surgery, nitrous oxide was discontinued and 
the patient had 0.5% isoflurane in oxygen for the purpose 
of post-extubation laryngoscopy. Residual neuromuscular 
paralysis was antagonized with a combination of atropine 1.2 
mg and neostigmine 2.5 mg iv. With adequate spontaneous 
tidal exchange, i.v. lidocaine 1.5 mg/kg was administered 
2 min before tracheal extubation. A post extubation 
laryngoscopy revealed normal vocal cord movements.









1st test 9.8 29.0 0.10
2nd test 11.8 27.0 0.20
3rd test 6.2 22.0 0.25
4th test 5.4 16.0 0.30
5th test 5.8 12.3 0.30
ng/ml - Nanogram per ml. µIU/ml - Micro international units per ml;  
T3- Tri-iodothyronine, T4- Thyroxine, TSH - Thyroid stimulating Hormone 
484 Nigerian Journal of Clinical Practice • Oct-Dec 2011 • Vol 14 • Issue 4
Bolaji, et al.: Anesthesia for thyroidectomy in a non-euthyroid patient
Postoperatively, oxygen was administered via nasal prongs 
at a flow rate of 2l/min in the recovery room. He was 
transferred to the ward fully conscious with stable vital signs. 
Post operative analgesia was ensured with intramuscular 
pethidine 100 mg 6 hourly for 48 hours followed by oral 
paracetamol 1000mg t.i.d. for three days. The patient was 
discharged home on the 10th postoperative day.
Discussion
There are three distinct treatments for hyperthyroidism; 
antithyroid medications, thyroidectomy, and radioiodine 
(131I).[7] Medical treatment consists of antithyroid 
drugs (propylthyouracil, methimazole, or carbimazole), 
potassium or sodium iodide. β-adrenergic antagonists 
(propranolol) are often used to counteract the exaggerated 
sympathetic effects of hyperthyroidism. Radioiodine 
destroys thyroid cell function and is not readily available 
in our environment. 
The reported patient’s symptoms grew worse and elevated 
T3 and T4 levels persisted [Table 1] despite six months 
of medical treatment and he subsequently developed 
congestive cardiac failure. This could have been due to 
late presentation as diagnosis of hyperthyroidism was 
made only after three years of onset of the symptoms. This 
period was long enough to result in cardiac manifestations 
of hyperthyroidism. Secondly, the patient might not have 
been compliant on medical treatment due to the high cost 
of the drugs and long duration of treatment. Thirdly, due 
to logistic reasons, e.g., storage conditions, potencies of the 
drugs might not be guaranteed.
The patient was placed on steroid when thyroid hormone 
levels remained persistently high. Steroids cause a 
prompt reduction in the serum level of thyroid hormones, 
particularly T3.
[8]
However, there was clearly a failure of medical treatment 
in the control of thyrotoxicosis in this patient. Therefore, 
subtotal thyroidectomy in the presence of persistently 
elevated thyroid hormone levels became inevitable in this 
patient in order to prevent further deterioration of his 
cardiac function. Some surgeons promote thyroidectomy as 
the treatment of choice for Grave’s disease (the commonest 
cause of hyperthyroidism).[9] However, very few patients 
with uncomplicated Grave’s disease are treated by surgery 
in the United States and Europe.[10] Other indications for 
surgery include a co-existing nonfunctioning nodule or a 
nodule suggestive of cancer on fine needle aspiration, large 
toxic multinodular goitres and solitary toxic adenomas. 
Thyroidectomy still remains the main option of therapy 
in our environment after the patient has been rendered 
euthyroid with antithyroid drugs. 
Fentanyl and lidocaine were administered before induction 
of anesthesia to blunt the cardiovascular responses, which 
occur during laryngoscopy and intubation. These responses, 
which were not desirable in this patient with thyrotoxic heart 
disease, may even increase blood pressure and heart rate; 
cardiac arrhythmias may also occur. These cardiovascular 
changes can be attenuated by intravenous administration 
of lidocaine (1.5 mg/kg) 1−2 min, remifentanil (1.0 µg/kg) 1 
min, alfentanil (10−20 µg/kg) 2−3 min or fentanyl (0.5−1.0 
µg/kg) 4−5 min before laryngoscopy.[11] Thiopental, used 
for induction of anesthesia in this patient, is an agent of 
choice because it possesses some antithyroid activity at high 
doses.[4] Indirect-acting adrenergic agonists that stimulate 
the sympathetic nervous system such as ketamine and 
pancuronium were avoided in the anesthetic management 
of this patient. Atracurium that was used for neuromuscular 
paralysis in this patient is cardiostable. Isoflurane, used 
for maintenance of anesthesia causes less myocardial 
depression when compared with enflurane or halothane 
and arrhythmias are less common than with other agents.[12]
The most serious threat to hyperthyroid patients in 
the postoperative period is thyroid storm, which is 
characterized by hyperpyrexia, tachycardia, hypotension, 
and altered consciousness (agitation, delirium, coma). In the 
intraoperative period, it may mimic malignant hyperthermia. 
Treatment includes hydration and cooling, an esmolol 
infusion or intravenous propranolol (0.5 mg increments until 
the heart rate is less than 100 beats/min), propylthiouracil 
(250−500 mg every 6 h orally or by nasogastric tube) 
followed by sodium iodide (1 g intravenously over 12 h) and 
correction of any precipating cause. Cortisol (100−200 mg 
every 8 h) is recommended to prevent complications from 
co-existing adrenal gland suppression. This patient had an 
uneventful perioperative management. 
Conclusion
Thyroidectomy is traditionally performed in the hyperthyroid 
patient who has been rendered euthyroid with antithyroid 
drugs. Long standing hyperthyroidism may be complicated 
by cardiac disease and congestive heart failure. Failure 
of medical treatment may be an indication for surgery in 
order to prevent further deterioration of cardiac function. 
With precautionary measures put in place, it is possible to 
perform thyroidectomy in patients that can not be rendered 
euthyroid as was done in this case and in one centre in our 
environment.
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